PCC Issue Brief Addresses Growing Problem of Drug Shortages

Colorectal Cancer Screening Drugs Affected by Shortages

Share this post:

Annapolis, MD / PRWeb / October 9, 2014 – Preventing Colorectal Cancer (PCC) has released the eighth issue brief in a series that underscores the importance of increasing U.S. colorectal cancer (CRC) screening rates, and highlights the obstacles and opportunities that influence efforts to achieve this goal. Issue Brief #8, Drug Shortages Impact Colorectal Cancer, discusses the severe problems that drug shortages pose for health care professionals and the health care industry. Propofol, which is commonly used in colorectal cancer screenings, has been affected by drug shortages in the recent past.

The new brief highlights which drugs are affected, what is causing the shortages and if there is a solution to this problem. “If we realize the mission of dramatically increasing screening rates among Americans, drug shortages could prove to become an even bigger issue than it is today,” says Stanford R. Plavin, MD, PCC board vice chair and president, Ambulatory Anesthesia of Atlanta.

PCC launched the issue brief series to educate key stakeholders on the importance of increasing screening rates among the U.S. population. The series is a compelling resource for physicians, patients, payors, public policy experts and others who can take action to make a difference and serve as champions for patient safety.

Previous issue briefs in the series can be found here. Topics include:

  • Colonoscopies Prevent Colon Cancer
  • Preventing Colorectal Cancer: The Benefit of Propofol
  • Health Insurers Should Cover Propofol Sedation
  • Why We Need Pricing Transparency
  • The Impact of Health Insurance Reform on Colorectal Cancer
  • FDA Approves SEDASYS Device
  • Take Advantage of the Patient Protection and Affordable Care Act Preventive Care Clause, Get Screened for Colorectal Cancer via Colonoscopy

PCC hopes the issue brief series will save lives by providing the information and guidance needed to educate the public, policymakers and other key stakeholders regarding colorectal cancer screening coverage, including safe sedation options.


Those interested may visit www.preventingcolorectalcancer.org  to sign up to receive the issue briefs as they become available via email. The website also contains other valuable resources and information on CRC and prevention efforts.


About Preventing Colorectal Cancer (www.preventingcolorectalcancer.org)

Headquartered in Annapolis, MD, Preventing Colorectal Cancer (PCC) preserves the tradition of safe, comfortable and quality-based medicine. PCC is a not-for-profit 501(c) 6 advocacy organization with the primary mission to educate both public and private stakeholders about the opportunities to reduce the incidence of colorectal cancer through promoting effective screening, prevention and care options for patients. Membership is open to all individuals and groups.

Scroll to Top